- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
AZN
How to Invest in a Post-COVID World
Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively.
3 Big Reasons the Dow Just Crossed 30K
The Dow just crossed 30,000 for the first time ever. Dive in to learn more about the three reasons behind this record move.
Don’t Be Fazed by the Recent Market Volatility
Don't be misled by worrisome headlines by the fearmongering media. The market should only get better from here. Use any weakness to pick up high quality stocks with strong fundamentals.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
5 Top Stock Trades for Thursday: MRNA, AZN, AAL, BYND, UNH
Moderna, UnitedHeath, Beyond Meat, American Airlines and AstraZeneca were our top stock trades from Wednesday -- and here's why.
4 Top Stock Trades for Friday: NVDA, LULU, TJX, AZN
Lululemon Athletica, Nvidia, TJX Companies and AstraZeneca were our top stock trades for Friday. That said, let's look at the charts.
First-Mover Advantage Will Benefit Amarin Stock More Than You Think
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
Amarin Has the Makings for a Gamechanging Product
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.